Refractory chronic migraine: is drug withdrawal necessary before starting a therapy with onabotulinum toxin type A?

Autor: Butera, Calogera1 butera.carla@hsr.it, Colombo, Bruno1, Bianchi, Francesca1, Cursi, Marco1, Messina, Roberta1, Amadio, Stefano1, Guerriero, Roberta1, Comi, Giancarlo1, Carro, Ubaldo1, Del Carro, Ubaldo2 (AUTHOR)
Zdroj: Neurological Sciences. Oct2016, Vol. 37 Issue 10, p1701-1706. 6p. 1 Diagram, 1 Chart.
Databáze: Academic Search Ultimate